Direct-to-Consumer Laboratory Testing Market (Sample Type: Blood, Urine, Saliva, and Others; Test Type: Genetic Testing, Disease Risk Assessment Testing, CBC, Diabetes Testing, TSH Testing, and Others; and End User: Hospitals, Clinics, Specialty Labs, and Diagnostic Centers) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2030

The global Direct-to Consumer Laboratory Testing market gathered revenue around USD 6.12 billion in 2021 and market is set to grow USD 35.4 billion by the end of 2030 and is estimated to expand at a modest CAGR of 26.9% during the prediction period 2022 to 2030.

Growth Factors:

Direct-to-consumer (DTC) laboratory testing, also known as direct access testing, enables patients to order tests directly from a laboratory without having to go through their healthcare practitioner. These test results can be used to track a current health condition, diagnose a previously undiagnosed medical issue, or provide information on personal health traits. DTC laboratory testing is an important part of ongoing attempts to improve people's engagement in their healthcare, and it is critical that the results are accurate and accessible. Laboratory professionals play a critical part in this process.

The prevalence of various lifestyle-associated and infectious diseases such as obesity, hypertension, diabetes, cancer, and STD has increased. This is likely to augment the demand for direct-to-consumer (DTC) laboratory testing for early diagnosis. According to the Centers for Disease Control and Prevention, heart diseases account for nearly 655,000 deaths in the U.S. each year. Cancer is a leading cause of death across the world. A majority of cancer cases are caused due to lifestyle-related factors. Various DTC test kits are available for testing and detection of both health and lifestyle-related diseases.

Moreover, a surge in the demand for early disease detection & diagnosis coupled with personalized medicines is anticipated to drive the direct-to-consumer (DTC) laboratory testing market. Furthermore, an increase in the geriatric population vulnerable to chronic illnesses drives the demand for direct-to-consumer laboratory testing. The direct-to-consumer laboratory testing market in Asia Pacific is expected to expand at a CAGR of 32.6% from 2022 to 2030. Increased awareness initiatives and developments conducted by government organizations to promote genetic research in countries across Asia are anticipated to drive the market in the region.

Report Scope of the Direct-to Consumer Laboratory Testing Market

Report Coverage

Details

Market Size

US$ 35.4 Billion by 2030

Growth Rate

CAGR of 26.9% from 2022 to 2030

Largest Market

North America

Fastest Growing Market

Asia Pacific

Base Year

2021

Forecast Period

2022 to 2030

Segments Covered

Sample Type, Test Type, End User and Region,

Companies Mentioned

 Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, and 23andMe, Inc., EverlyWell, Inc., DirectLabs, LLC, Ancestry, MyMedLab, Inc., WellnessFX, ANY LAB TEST NOW, LetsGetChecked, and Color Genomics..

Increase in Emphasis on Patient-driven Healthcare to Fuel Market Growth

The direct-to-consumer laboratory testing has highly impacted patient care, its cost, and the role of the laboratory professional. These tests are also referred as consumer-driven testing. In the era of the Internet and social media, consumers seek more control over their health and are willing to pay for this service. The reasons often cited for ordering DTC lab tests include convenience, preparing for a doctor visit, saving money, privacy, getting a second opinion, and obtaining tests not covered by insurance.

Retail outlets such as Walmart, Sam’s Club, and Costco provide one-stop healthcare services. These services include onsite testing for glucose and cholesterol, as well as tests that are later sent out to reference laboratories. Moreover, telemedicine kiosks are available in some outlets with access available to physicians either by telephone or the Internet. Hence, surge in emphasis on patient-driven healthcare and easy access to patients as consumers through the Internet and media are expected to drive the direct-to-consumer laboratory testing market.

Genetic Testing Dominated Direct-to-Consumer Laboratory Testing Market

Based on test type, the global direct-to-consumer laboratory testing market has been classified into genetic testing, disease risk assessment testing, CBC, diabetes testing, TSH testing, and others. The disease risk assessment testing segment has been split into cancer, STDs, and others. The genetic testing segment dominated the global direct-to-consumer laboratory testing market in 2021, and the trend is anticipated to continue during the forecast period. The dominance can be attributed to the increase in consumer awareness, emerging culture of consumer empowerment, and demand for increasingly personalized services. Moreover, an increase in the number of market players offering direct-to-consumer genetic test kits is also projected to augment the segment.

Saliva to be Preferred Sample Type

Based on sample type, the global direct-to-consumer laboratory testing market has been classified into blood, urine, saliva, and others. The saliva segment held a major share of the market in 2021. The segment is anticipated to expand at a significant CAGR during the forecast period. The significant increase in the number of users of key market players, such as Ancestry and 23andme, offering saliva based DNA test is anticipated to boost the segment.

Diagnostic Centers Held Major Share of Direct-to-Consumer Laboratory Testing Market

In terms of end user, the global direct-to-consumer laboratory testing market has been split into hospitals, clinics, specialty labs, and diagnostic centers. The diagnostic centers segment dominated the market in 2021. Focus of new entrants on establishment of standalone laboratories is a key factor that is projected to propel the segment during the forecast period.

North America to Lead Global Market, Asia Pacific to Offer Significant Opportunities

In terms of region, the global direct-to-consumer laboratory testing market has been segmented into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. North America is projected to account for a prominent share of the global direct-to-consumer laboratory testing market during the forecast period. The rise in prevalence of various lifestyle associated and infectious diseases such as obesity, diabetes, cancer, and STD is estimated to boost the demand for direct-to-consumer laboratory testing for early diagnosis in North America during the forecast period. The market in Europe is anticipated to expand at a high CAGR in the near future. The rise in consumer awareness and enhancing lifestyles are also projected to fuel the market.

The direct-to-consumer laboratory testing market in Asia Pacific is projected to expand at a rapid pace in the near future. This can be attributed to increased awareness initiatives and developments conducted by government organizations to promote genetic research in countries across Asia.

Some of the prominent players in the Direct-to Consumer Laboratory Testing Market include:

  • Laboratory Corporation of America Holdings
  • Quest Diagnostics Incorporated
  • 23andMe, Inc.
  • EverlyWell, Inc.
  • DirectLabs, LLC
  • Ancestry
  • MyMedLab, Inc.
  • WellnessFX
  • ANY LAB TEST NOW
  • LetsGetChecked
  • Color Genomics

Segments Covered in the Report

This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for the period of 2017 to 2030 and covers subsequent region in its scope:

Global Direct-to-Consumer Laboratory Testing Market: Segmentation

Direct-to-Consumer Laboratory Testing Market, by Sample Type

  • Blood
  • Urine
  • Saliva
  • Others

Direct-to-Consumer Laboratory Testing Market, by Test Type

  • Genetic Testing
  • Disease Risk Assessment Testing
    • Cancer
    • STDs
    • Others
  • CBC
  • Diabetes Testing
  • TSH Testing
  • Others

Direct-to-Consumer Laboratory Testing Market, by End User

  • Hospitals
  • Clinics
  • Specialty Labs
  • Diagnostic Centers

By Geography

North America

  • U.S.
  • Canada

Europe

  • Germany
  • France
  • United Kingdom
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Southeast Asia
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Rest of Latin America

Middle East & Africa (MEA)

  • GCC
  • North Africa
  • South Africa
  • Rest of Middle East & Africa

Key Points Covered in Direct-to Consumer Laboratory Testing Market Study:

  • Growth of Direct-to Consumer Laboratory Testing in 2022
  • Market Estimates and Forecasts (2017-2030)
  •  Brand Share and Market Share Analysis
  •  Key Drivers and Restraints Shaping Market Growth
  •  Segment-wise, Country-wise, and Region-wise Analysis
  •  Competition Mapping and Benchmarking
  •  Recommendation on Key Winning Strategies
  •  COVID-19 Impact on Demand for Direct-to Consumer Laboratory Testing and How to Navigate
  •  Key Product Innovations and Regulatory Climate
  •  Direct-to Consumer Laboratory Testing Consumption Analysis
  •  Direct-to Consumer Laboratory Testing Production Analysis
  •  Direct-to Consumer Laboratory Testing and Management